Rapid Infuser Market Size, Trends, Company Profiles, Growth Rate, Revenue, Demand and Forecast 2030

04/gen/2021 07:17:59 Ankush Nikam Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The global  rapid infuser market  is slated to expand at a CAGR of 4.6% amid 2020 to 2030. As demand for effective treatment options for hypothermia and excessive blood loss in operative settings and trauma grows, implementation of novel techniques, comprising rapid infusers is foreseeing growth .

"Increasing number of surgical procedures and increased risk of hypovolemia and hypothermia is fueling the global rapid infusers market. These are widely reflected as vital intervention in life-threatening ailments for instance sepsis, thus are gaining traction amid the forecast period." says an FMI analyst.

Request a report sample to gain comprehensive market insights at  https://www.futuremarketinsights.com/reports/sample/rep-gb-6716

Key Highlights

  • North America to remain dominant in the global market as the region is home to leading market players.
  • Trolley mounted devices is anticipated to witness increased demand, capturing 70% of the overall market.
  • Reusable rapid infusers will be foreseeing high demand due to cost benefits to healthcare facilities.
  • Hospitals to account for more than 60% of the overall market throughout the forecast period.


  • Growing use of hypothermia in cases of blood loss or trauma during surgery, is boosting demand for rapid infuser.
  • Significant demand for blood, plasma, & crystalloid fluids, furthers massive transfusion application, thus paving way for market growth.
  • Surge in ambulatory healthcare facilities is anticipated to generate prospects in the market


  • Higher cost associated with the conventional rapid infusion devices is a key concern hampering the adoption.
  • Slow implementation of rapid infusion devices in hospitals, particularly in emerging nations and rural areas due to poor awareness, impacts market prospects.

For any Queries Linked with the Report, Ask an Analyst @  https://www.futuremarketinsights.com/ask-question/rep-gb-6716

COVID-19 Impact on the Market

The market demand for rapid infuser has been marginally impacted due to disruptions of component and raw material supplies caused by lockdown and trade restrictions. Nonetheless, the essential nature of the products, makes the sector chiefly exempted from government restrictions. Demand is unlikely to change considerably even in the post-pandemic duration since applications in ICUs, gynecology, and urology continues to remain unchanged.

Competitive Landscape

Key rapid infuser companies active in the moderately consolidated market are majorly engaged in research & development strategies to broaden their product portfolios. Companies are further seeking strategic acquisitions & mergers to bolster capacity expansion and geographic presence.

Key companies identified in the global market are GE Healthcare Inc., 3M, Stryker Corp., Smith's Group Plc, ZOLL Medical Corp., Teleflex Inc., Becton, Belmont Instrument Corporation, Dickinson and Company, 410 Medical, Soma Technology Inc., and Smisson-Catledge Biomedical.

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl